The company’s 2019 equity incentive plan is designed to help it add and retain talented employees by leveraging equity participation incentives The plan is aimed at motivating individuals who perform services for CIIX CIIX CEO…
TGOD is dedicated to high standards in the midst of a growing cannabis supply gap The company is increasing production rates and margins through its alliance with Eaton Corp. and its use of high-tech hybrid…
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that PharmHouse Inc., its 49 percent-owned joint venture, has received a cultivation license from Health Canada. According to the update, PharmHouse will immediately commence operations…
The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, recently unveiled its plan to enter the global hemp-CBD market by announcing the launch of its Global Strategic Hemp Division. An…
INmune Bio (NASDAQ: INMB) is an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, such as Alzheimer’s disease (“AD”). A recent article discussing the company reads, “An…
CIIX is a leading financial information provider for Chinese-speaking investors The company’s emphasis is on providing dependable market information to assist investors in making wise investment decisions CIIX is leveraging initiatives in the cryptocurrency space…
Pareteum is building on sales and acquisition successes by joining the Russell 3000 Index, granting the company a higher investment profile Pareteum’s cloud platform and related services connect millions of people in dozens of countries…
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company, this morning announced entry of its wholly owned subsidiary, Khrysos Industries, into a one year supply and processing agreement to produce water soluble CBD Isolate, which…
TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently named Alan R. Applonie as general manager of its Modesto facility (http://ibn.fm/ndEOZ). A recent article discussing the company reads, “The appointment was made after screening of top-tier talent from…
Biotechnology company Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) recently reported that clinical lab tests conducted with live animals demonstrated that its new, enhanced version of DehydraTECH(TM) can deliver eight times more CBD into the blood…
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, this morning announced that its flagship Barocycler 2320EXTREME was…
Research indicates that anti-inflammatory medications have the power to prevent the onset and control the symptoms of Alzheimer’s disease The link between inflammatory processes and Alzheimer’s has long been established; companies like INmune Bio are…
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning released its financial results for the three and twelve months ended March 31, 2019. Audited consolidated financial statements for Canopy Rivers for the twelve months ended March…
ETST product sales rose to $770,635 for fiscal 2019, up from $463,108 in the previous year The company cited expanded distribution, increased customer awareness and rising demand for branded, high-grade, full-spectrum cannabinoid products as reasons…
Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), parent company of Organigram Inc., a leading licensed producer of cannabis, today announced its financial results for its fiscal third quarter ended May 31, 2019. “We continued to…
TGOD is expanding into the global organic-hemp CBD market with its Global Strategic Hemp Division; the global CBD market is forecast to reach $22 billion in three years The company’s flagship Quebec facility received organic…
Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its receipt of a purchase order from American Eagle Outfitters, Inc. (NYSE: AEO), through which it will sell hemp-derived cannabidiol (“CBD”) infused personal…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTC: LXRP) today announced its entry into a definitive five-year agreement, via its subsidiary Lexaria Hemp Corp., to provide its patented DehydraTECH(TM) technology to…
CIIX CEO forecast that the company’s sales will reach $11-12 million by 2020 during an interview with Redchip Money Report CIIX recently opened a hemp-based CBD product retail store in the Chinese-concentrated area of San…
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announced its entry into a definitive 5-year agreement, via its subsidiary Lexaria Hemp Corp, with Nic’s Beverages L.L.C. Under the…